Slide 2:
Ali Lankarani, MD
3rd year GI fellow
Allegheny General Hospital / Drexel University
Pittsburgh Manish K. Dhawan, MD Disclaimer:
Not an endosonographer
Pancreatic Cancer :
Pancreatic Cancer Forth-leading cause of cancer death in USA
In 2010 and 35,240 will die from this cancer
5-year survival rate = 5.5% EUS alone is not specific
EUS-FNA is the modality of choice for obtaining tissue
Tissue diagnosis is mandatory before chemotherapy
Slide 4:
Onsite cytopathologist, if available, can confirm the adequacy of sample More than one needle pass is usually needed
Identifying the factors that may influence the number of FNA passes: :
Identifying the factors that may influence the number of FNA passes: Review of the past 6 yrs data of the patients that were diagnosed with pancreatic cancer (n=188)
Analyze the effect of the following variations:
FNA needle size
Location of the mass
Size of the tumor
Endosonographer’s experience
Slide 6:
Endosonographer’s experience Location of the tumor